MX9202190A - 2-carboxiindoles substituidos que tienen actividad farmaceutica. - Google Patents

2-carboxiindoles substituidos que tienen actividad farmaceutica.

Info

Publication number
MX9202190A
MX9202190A MX9202190A MX9202190A MX9202190A MX 9202190 A MX9202190 A MX 9202190A MX 9202190 A MX9202190 A MX 9202190A MX 9202190 A MX9202190 A MX 9202190A MX 9202190 A MX9202190 A MX 9202190A
Authority
MX
Mexico
Prior art keywords
carboxyindoles
novel compounds
substituted
methods
well
Prior art date
Application number
MX9202190A
Other languages
English (en)
Inventor
Graham Johnson
Thomas Charles Malone
Po-Wai Yuen
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9202190A publication Critical patent/MX9202190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invención se relaciona con compuestos novedosos, que son derivados de ureas, tioureas, carbamatos, sulfonilureas, sulfonamidas, amidas y tioamidas de 2-carboxiindoles. La invención se relaciona con los métodos para la preparación de los compuestos novedosos, así como las composiciones farmacéuticas o métodos de uso para los compuestos novedosos, así como con las composiciones farmacéuticas o métodos de uso para los compuestos novedosos. De manera más específica, los compuestos de la presente invención son útiles en el tratamiento de transtornos neurodegenerativos incluyendo transtornos cerebrovasculares así como en el tratamiento de esquizofrenia o epilepsia, y como analgésicos y ansiolíticos.
MX9202190A 1991-05-14 1992-05-12 2-carboxiindoles substituidos que tienen actividad farmaceutica. MX9202190A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/699,875 US5145845A (en) 1991-05-14 1991-05-14 Substituted 2-carboxylindoles having pharmaceutical activity

Publications (1)

Publication Number Publication Date
MX9202190A true MX9202190A (es) 1993-08-01

Family

ID=24811282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202190A MX9202190A (es) 1991-05-14 1992-05-12 2-carboxiindoles substituidos que tienen actividad farmaceutica.

Country Status (4)

Country Link
US (1) US5145845A (es)
IE (1) IE921526A1 (es)
MX (1) MX9202190A (es)
WO (1) WO1992020649A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217991A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Cycloalkyl/cycloalkylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
US5217988A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Indolyl indolylakyl-N-terminal cycloalkoxy-C-terminal amino hydroxyβ-amino acid derivatives
US5216013A (en) * 1989-12-04 1993-06-01 G. D. Searle & Co. Aralkyl-N-terminal cycloalkoxy-C terminal amino hydroxy β-amino acid derivatives
US5217989A (en) * 1989-12-04 1993-06-08 G. D. Searle & Co. Benothiophenyl/benzothiophenylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5713700A (en) * 1993-06-14 1998-02-03 Dipl-Inc. Dr. Ernst Vogelsang Gmbh & Co.Kg Method of providing subterranean cable systems
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (es) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5403851A (en) * 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2735129B1 (fr) * 1995-06-07 1997-07-11 Adir Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU6386196A (en) * 1995-06-19 1997-01-15 Eli Lilly And Company Process for parallel synthesis of a non-peptide library
WO1997006141A1 (fr) * 1995-08-04 1997-02-20 Otsuka Kagaku Kabushiki Kaisha Derives des esters de l'acide indole-2-carboxylique, et bactericides destines a l'agriculture et a l'horticulture contenant ceux-ci comme ingredients actifs
US5773434A (en) * 1995-08-30 1998-06-30 Gary A. Rogers Facilitation of AMPA receptor-mediated synaptic transmission in brain as a treatment for schizophrenia
US6277878B1 (en) * 1998-09-07 2001-08-21 Pfizer Inc Substituted indole compounds as anti-inflammatory and analgesic agents
GB9902459D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
DE10153346A1 (de) * 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
US20040122218A1 (en) * 2002-12-20 2004-06-24 Sean Turner Pyrrolopyridine potassium channel openers
JP2008519761A (ja) * 2004-11-09 2008-06-12 スミスクライン ビーチャム コーポレーション グリコーゲンホスホリラーゼ阻害化合物およびその医薬組成物
WO2010149755A1 (en) * 2009-06-26 2010-12-29 Novartis Ag 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
EP2702052B1 (en) 2011-04-28 2017-10-18 Novartis AG 17alpha-hydroxylase/c17,20-lyase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364224A (en) * 1961-06-27 1968-01-16 Warner Lambert Pharmaceutical Acylated derivatives of 1, 2, 3, 4-tetrahydro-1-oxo-beta-carbolines
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
DE1212520B (de) * 1963-12-03 1966-03-17 Bayer Ag Verfahren zur Herstellung von Iminokohlensaeureesterderivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
GB8531612D0 (en) * 1985-12-23 1986-02-05 Beecham Wuelfing Gmbh & Co Kg Compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc

Also Published As

Publication number Publication date
WO1992020649A3 (en) 1993-01-07
IE921526A1 (en) 1992-11-18
WO1992020649A2 (en) 1992-11-26
US5145845A (en) 1992-09-08

Similar Documents

Publication Publication Date Title
MX9202190A (es) 2-carboxiindoles substituidos que tienen actividad farmaceutica.
AR002289A1 (es) Derivados de acetamida, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y las aplicaciones de dichos compuestos comoansioliticos y en el tratamiento de enfermedades inmuno-inflamatorias.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ECSP056019A (es) 2,4-di(fenilamino)pirimidinas útiles en el tratamiento de enfermedades neoplásicas, trastornos inflamatorios y del sistema inmune
ES2169127T3 (es) Nuevos carbamatos y ureas como modificadores de la resistencia multi-farmaco.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
PA8442201A1 (es) Derivados de 6-fenilpiridil-2-amina
AR007118A1 (es) 4(3h)-quinazolinonas 2,3 disustituidas y composiciones farmaceuticas que las contienen
PA8481301A1 (es) Derivados de 4,4-biarilpiperidina
ECSP034797A (es) DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA COMO ANTAGONISTAS II MGLUR2
ES2038613T3 (es) Procedimiento para preparar derivados de 4,5,6,7-tetrahidro-1h-imidazo(4,5-c)piridina y analogos de los mismos que tienen actividad antihipertensiva.
ECSP055719A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
PA8609201A1 (es) Piridinonas sustituidas
SV1998000029A (es) Compuestos de pirazina ref. pg3186
AR029025A1 (es) Derivados de adenosina n6 heterociclicos 5' modificados, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de un medicamento
SE9702564D0 (sv) New compounds
AR014747A1 (es) Derivados de piperidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, una composicion farmaceutica que loscontiene y un procedimiento para obtener esta composicion farmaceutica
ES2072263T3 (es) Derivados de 4-aminopiridina.
PA8458301A1 (es) 2-aminopiridinas con sustituyentes alcoxi ramificados
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.
ES2093782T3 (es) Piridazindionas y su uso en el tratamiento de trastornos neurologicos.
SV1998000023A (es) Arilsulfonamidas y analogos ref. lea 32316-sv
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
AR019322A1 (es) Derivados de sulfonilo sustituido por heterociclo-etanodionanilina sustituida por heterociclo, composicion farmaceutica que los contiene y su uso para lamanufactura de un medicamento